Your browser doesn't support javascript.
loading
Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection.
Mukherjee, Rukmini; Bhattacharya, Anshu; Bojkova, Denisa; Mehdipour, Ahmad Reza; Shin, Donghyuk; Khan, Khadija Shahed; Hei-Yin Cheung, Hayley; Wong, Kam-Bo; Ng, Wai-Lung; Cinatl, Jindrich; Geurink, Paul P; van der Heden van Noort, Gerbrand J; Rajalingam, Krishnaraj; Ciesek, Sandra; Hummer, Gerhard; Dikic, Ivan.
  • Mukherjee R; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt, Germany; Max Planck Institute of Biophysics, Frankfurt, Germany.
  • Bhattacharya A; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt, Germany.
  • Bojkova D; Institute of Medical Virology, University Hospital Frankfurt, Frankfurt, Germany.
  • Mehdipour AR; Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt, Germany.
  • Shin D; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt, Germany; Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Khan KS; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong, Hong Kong.
  • Hei-Yin Cheung H; State Key Laboratory of Agrobiotechnology, School of Life Sciences, The Chinese University of Hong Kong (CUHK), Hong Kong, Hong Kong.
  • Wong KB; State Key Laboratory of Agrobiotechnology, School of Life Sciences, The Chinese University of Hong Kong (CUHK), Hong Kong, Hong Kong.
  • Ng WL; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong, Hong Kong.
  • Cinatl J; Institute of Medical Virology, University Hospital Frankfurt, Frankfurt, Germany.
  • Geurink PP; Oncode Institute and Department of Chemical Immunology, Leiden University Medical Centre, Leiden, The Netherlands.
  • van der Heden van Noort GJ; Oncode Institute and Department of Chemical Immunology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Rajalingam K; Cell Biology Unit, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Ciesek S; Institute of Medical Virology, University Hospital Frankfurt, Frankfurt, Germany; Institute of Pharmaceutical Biology, Goethe-University, Frankfurt, Germany; Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Branch Translational Medicine and Pharmacology, Frankfurt, Germany.
  • Hummer G; Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt, Germany; Institute of Biophysics, Goethe University Frankfurt, Frankfurt, Germany.
  • Dikic I; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt, Germany; Max Planck Institute of Biophysics, Frankfurt, Germany; Fraunhofer Institute for Molecular Biology and Applied Ecology (IME
J Biol Chem ; 297(2): 100925, 2021 08.
Article en En | MEDLINE | ID: mdl-34214498
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Famotidina / Receptor Toll-Like 3 / SARS-CoV-2 / Antagonistas de los Receptores Histamínicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Famotidina / Receptor Toll-Like 3 / SARS-CoV-2 / Antagonistas de los Receptores Histamínicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article